Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-014429
Filing Date
2022-06-06
Accepted
2022-06-06 17:01:02
Documents
1
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3158
  Complete submission text file 0001437749-22-014429.txt   4627
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
AUERBACH ALAN H (Reporting) CIK: 0001358285 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 22998764

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations